[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Raut S, Shah S, Shah K, Patel K, Talati S, Parikh S, Anand A, Panchal H, Patel A, Jain A. Improving Outcome of Hodgkins Disease with Autologous Hematopoietic Stem Cell Transplantation. Indian J Hematol Blood Transfus. 2016;32(2):176-181.
Raut S, Shah S, Shah K, Patel K, Talati S, Parikh S, Anand A, Panchal H, Patel A. Improving Outcome of Thalassemia with Hematopoetic Stem Cell Transplantation: An Experience of Gujarat Cancer Research Institute. Indian J Hematol Blood Transfus. 2016;32(3):284-291.
Raute K, Strietz J, Parigiani MAlejandra, Andrieux G, Thomas OS, Kistner KM, Zintchenko M, Aichele P, Hofmann M, Zhou H, et al. Breast Cancer Stem Cell-Derived Tumors Escape from γδ T-cell Immunosurveillance In Vivo by Modulating γδ T-cell Ligands. Cancer Immunol Res. 2023:OF1-OF20.
Rautenberg C, Kaivers J, Germing U, Haas R, Schroeder T, Kobbe G. Spontaneous remission in a patient with very late relapse of acute myeloid leukemia 17 years after allogeneic blood stem cell transplantation. Eur J Haematol. 2019.
Rauwolf K, Herbrüggen H, Zöllner S, Thorer H, Makarova O, Kaiser T, Pettke A, Rossig C, Burkhardt B, Groll AH. Durable control of Hepatitis C through interferon-free antiviral combination therapy immediately prior to allogeneic hematopoietic stem cell transplantation. J Viral Hepat. 2018.
Ravaglia C, Poletti V. Bronchiolitis and Bronchiolar Disorders. Semin Respir Crit Care Med. 2020;41(2):311-332.
Ravagnani FG, Valerio HP, Maués JHS, de Oliveira AN, Puga RD, Griesi-Oliveira K, Picosse FR, Ferraz HB, Catharino RR, Ronsein GE, et al. Omics profile of iPSC-derived astrocytes from Progressive Supranuclear Palsy (PSP) patients. Parkinsonism Relat Disord. 2023;116:105847.
Raval KK, Kamp TJ. Cardiomyopathy, mitochondria and Barth syndrome: iPSCs reveal a connection. Nat Med. 2014;20(6):585-586.
Raval JS, Park YA, Perjar I, Mazepa MA, Vincent BG, Ma AD, Rollins-Raval MA. Heparin-induced thrombocytopenia associated with collection of hematopoietic progenitor cells by apheresis. J Clin Apher. 2019.
Raval AN, Johnston PV, Duckers HJ, Cook TD, Traverse JH, Altman PA, Dhingra R, Hematti P, Borrello I, R Anderson D, et al. Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort. Int J Cardiol. 2020.
Ravandi F, Jorgensen JL, Thomas DA, O'Brien S, Garris R, Faderl S, Huang X, Wen S, Burger JA, Ferrajoli A, et al. Detection of MRD may predict the outcome of patients with Philadelphia-chromosome positive ALL treated with tyrosine kinase inhibitors plus chemotherapy. Blood. 2013.
Ravandi F, Jorgensen JL, O'Brien SM, Jabbour E, Thomas DA, Borthakur G, Garris R, Huang X, Garcia-Manero G, Burger JA, et al. Minimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with acute lymphoblastic leukaemia. Br J Haematol. 2015.
Ravandi F, Assi R, Daver N, Benton CB, Kadia T, Thompson PA, Borthakur G, Alvarado Y, Jabbour EJ, Konopleva M, et al. Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 study. Lancet Haematol. 2019.
Ravandi F, Kreitman RJ, Tiacci E, Andritsos L, Banerji V, Barrientos JC, Bhat SA, Blachly JS, Broccoli A, Call T, et al. Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. Blood Cancer J. 2022;12(12):165.
Ravandi F, Cloos J, Buccisano F, Dillon R, Döhner K, Freeman SD, Hourigan CS, Ossenkoppele GJ, Roboz GJ, Subklewe M, et al. Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower-intensity therapy: Roadmap from an ELN-DAVID expert panel. Am J Hematol. 2023.
Ravandi F, Döhner H, Wei AH, Montesinos P, Pfeilstöcker M, Papayannidis C, Lai Y, Wang K, See WL, de Menezes DLopes, et al. Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML-001. Br J Haematol. 2023.
Ravandi R, Heris SZeinali, Hemmati S, Aghazadeh M, Davaran S, Abdyazdani N. Effects of chitosan and TiO nanoparticles on the antibacterial property and ability to self-healing of cracks and retrieve mechanical characteristics of dental composites. Heliyon. 2024;10(6):e27734.
Ravari MKhozaei, Mashayekhan S, Zarei F, Sayahpour FAzam, Taghiyar L, Eslaminejad MBaghaban. Fabrication and characterization of an injectable reinforced composite scaffold for cartilage tissue engineering: Anstudy. Biomed Mater. 2021.
Ravari MKhozaei, Mashayekhan S, Zarei F, Sayyahpour FAzam, Taghiyar L, Eslaminejad MBaghban. Fabrication and characterization of an injectable reinforced composite scaffold for cartilage tissue engineering: an in vitro study. Biomed Mater. 2021;16(4):045007.
Ravasio R, Ceccacci E, Minucci S. Self-renewal of tumor cells: epigenetic determinants of the cancer stem cell phenotype. Curr Opin Genet Dev. 2016;36:92-99.
Raveenthiraraj S, Awanis G, Chieppa M, O'Connell AE, Sobolewski A. M1 and M2 Macrophages Differentially Regulate Colonic Crypt Renewal. Inflamm Bowel Dis. 2023.
Ravi NSam, Wienert B, Wyman SK, Bell HWilliam, George A, Mahalingam G, Vu JT, Prasad K, Bandlamudi BPrasad, Devaraju N, et al. Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin. Elife. 2022;11.
Ravi VM, Will P, Kueckelhaus J, Sun N, Joseph K, Salié H, Vollmer L, Kuliesiute U, von Ehr J, Benotmane JK, et al. Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma. Cancer Cell. 2022;40(6):639-655.e13.
Ravi S, Chokkakula LPPavithra, Giri PShankar, Korra G, Dey SRanjan, Rath SNarayan. 3D Bioprintable Hypoxia-Mimicking PEG-Based Nano Bioink for Cartilage Tissue Engineering. ACS Appl Mater Interfaces. 2023.
Ravi P, Kumaresan S, Danaraj J, Uthirakrishnan U, Pandian S, Sivaramakrishnan R, Prakasam SBelcia, Pugazhendhi A. Anti-fouling potential and in-silico analysis of carotenoid and fatty acids from RauvolfiatetraphyllaL. Environ Res. 2023:116158.